THEY ARE NOT JUST PRESERVING ORGANS ANYMORE. THEY ARE REPAIRING THEM… — Mr. Pool — TG.ME

🔻 THEY ARE NOT JUST PRESERVING ORGANS ANYMORE. THEY ARE REPAIRING THEM. AND THE TRANSPLANT INDUSTRY IS PANICKING.

For seventy years, transplant medicine has followed one rule: keep the organ alive until it reaches the patient.

Slow the decay. Minimize the damage. Hope for the best.

That rule just changed.

A team of researchers published something this week that describes something entirely new:

Instead of just preserving donor organs, they are now repairing them while they wait.

The method is called mitochondrial transplantation.

Here is how it works:

When an organ is removed from a donor, it is connected to a machine that keeps it alive outside the body. This is called machine perfusion. It has been used for years.

But now, instead of just pumping blood through the organ, doctors are injecting healthy mitochondria directly into it.

The results are striking.

In pig hearts, transplanted mitochondria improved contractile recovery and cut infarct size by more than 75%. In lungs, they improved oxygenation and reduced inflammation. In kidneys, they stimulated metabolic activity and energy production.

The mitochondria enter the cells. They replace damaged organelles. They restore energy production. They rebalance inflammatory signaling.

The authors described it as a shift from “preservation” to “repair.”

Think about that.

An organ that would have been discarded as too damaged for transplant can now be reconditioned. Repaired. Made viable again.

This is not science fiction. This is published in a peer-reviewed medical journal.

The MedBed community has always said that the body can heal itself if given the right tools.

Now they are giving organs the tools to heal themselves before they even reach the patient.

The line between “preservation” and “regeneration” just disappeared.

And the transplant industry knows it.

The world must know the truth.
SHARE IT.



https://t.me/MrPool_Q
2❤55🙏34🔥9💯6⚡3👌3❤‍🔥2👍2🥰2🏆1🍾1
August 31, 2026 2.3K 36